Skip to content

Massage for Pediatric Oncology

Massage for Children Undergoing Bone Marrow Transplantation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00843180
Enrollment
23
Registered
2009-02-13
Start date
2008-11-30
Completion date
2010-01-31
Last updated
2012-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Marrow Transplantation, Distress

Keywords

Bone Marrow Transplant, Massage, Pediatric Oncology, children undergoing bone marrow transplantation

Brief summary

Undergoing bone marrow transplantation (BMT) is associated with a high level of distress for patients and caregivers. Clinical research studies have reported benefits from massage for a) oncology patients, b) children, c) adults and children undergoing bone marrow transplants. A multi-center study of an intervention using a combination of massage therapy and a laugh cart to reduce distress in pediatric oncology patients undergoing BMT (PI: Phipps) is completed with results not yet published. There is still a need for independent studies to isolate the effect of massage for clinical outcomes (such as improved nausea and pain control) in children. Furthermore, this study will test the acceptability of an augmented massage intervention. In addition to provider-child massage, the augmented massage intervention includes training of the resident parent to provide additional parent-child massage, to relieve symptoms as needed. The goal of this augmented intervention is the improvement of symptom management in patients and decreased stress and feelings of helplessness in parents. We propose a randomized pilot study at the UCSF pediatric bone marrow transplant center to assess the feasibility of a higher-quality study of the effects of massage in this population. Aim 1: Determine the acceptability of a massage intervention for patients and parents on a pediatric bone marrow transplant unit. Aim 2: Explore the logistics of implementing the augmented massage intervention at the bedside offered to consecutive patients over one year's time. Aim 3: Collect preliminary data for patients and parents including patient clinical outcomes, quality of life, and satisfaction, and parental stress and mood to allow sample size calculations for further studies.

Detailed description

This study is a pilot randomized controlled feasibility trial of an augmented massage intervention, compared to a usual-care control group, in which intervention group participants will receive up to 3 massage sessions per week, during the 4-6 hospitalization at UCSF for Bone Marrow Transplant (BMT). Participants will be approximately 24 children recruited from consecutive sample of pediatric cancer and non-cancer patients undergoing BMT age 5 to 18 admitted to UCSF children's hospital during one calendar year. Intervention: Massage sessions will be gentle Swedish style combine with acupressure and will range from 20-45 minutes, provided by credentialed and trained massage therapists; augmentation will involve massage training for the resident parent, who rooms with the patient, to administer massage to his/her child during the course of the hospital stay. The control group will receive standard-care. We will collect feasibility data and do exploratory comparison of clinical outcomes between groups. Knowledge to be gained: We will have preliminary data for a larger trial that will determine whether an augmented massage intervention can support symptom management in the pediatric BMT unit. B. Hypothesis(es): Briefly explain the hypothesis(es) to be tested. If the study is not designed to test a hypothesis, simply state None. Hypothesis 1a: \>60% of Patients are willing to be randomized to the massage study. Hypothesis 1b: 80% of patients randomized to massage will accept the massage intervention when offered. Hypothesis 1c: The majority of parents (\>60%) are willing to learn massage techniques for use on their children. Hypothesis 2a: Professional massage providers will be able to deliver massage, negotiating schedule, space, time, and other patient-related medical activities and will be able to schedule \>50% of planned massages. Hypothesis 2b: Massage providers will be able to assess the acceptable time period for massage (between 10 minutes and 45 minutes). Hypothesis 2c: Parents will carry out the massage on their children, will do at least 5 massages over the study period and are willing to provide a self-report of estimated time engaged in massage. Hypothesis 3a: 80% of patients will answer survey questions about their experience in general and the massage intervention. Hypothesis 3b: The RA will be able to collect clinical data from chart review and electronically stored lab data . Hypothesis 3c: 80% of parents will answer survey questions about their experience in learning and delivering massage, stress, mood, PTSD symptoms and self-efficacy around patient management.

Interventions

OTHERmassage

one to three massages per week by massage practitioner additional massages by resident parent who is being taught to massage her/his child

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Being 5 to 18 years old * Admitted for BMT. Rationale: This is a pediatric study for children up to age 18 admitted to the BMT unit. Questionnaires are not designed for children under age 5.

Exclusion criteria

* Parent or child unable to answer questionnaire due to language limitations. Rationale: The pilot character of the study with its limited budget does not include instruments in foreign languages, such as Chinese or Spanish. This could be a project for further studies.

Design outcomes

Primary

MeasureTime frameDescription
Number of Days With Pain Scores >3 Measured on Numeric Rating Scale (Range 0-10; 0 for no Pain; 10 for Worst Pain Imaginable)7 days pre to 21 days post transplant = 28 daysdays of pain \>3 by nurses notes based on pain scores on numeric rating scale (up to 28 days)

Secondary

MeasureTime frameDescription
Number of Vomiting Episodesday -7 to +21 around transplant datenumber of vomiting episodes as reported by nurses per occurence (no upper limit)
Days of Hospital Staydays of hospital stay after bone marrow transplantdays of hospital stay after bone marrow transplant (up to 100 days; participant observation was censored after 100 days)
Days to Recovery Neutrophil Counthospital staynumber of days to recovery neutrophil count \>500 cells per microliter for 2 consecutive days (range, up to 100 days, censored at 100 days)

Countries

United States

Participant flow

Recruitment details

November 2008-November 2009, 12 months UCSF Children's Hospital, Bone Marrow Transplant Unit

Pre-assignment details

consecutive enrollment of all eligible admitted children. 2 teenage boys declined participation

Participants by arm

ArmCount
Massage
massage and acupressure up to 3x/week for entire hospital stay
16
Control
usual care only as control arm hospital care during bone marrow transplant
7
Total23

Baseline characteristics

CharacteristicControlMassageTotal
Age, Categorical
<=18 years
7 Participants16 Participants23 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age Continuous13.7 years
STANDARD_DEVIATION 4.3
10.9 years
STANDARD_DEVIATION 3.7
11.7 years
STANDARD_DEVIATION 4
Region of Enrollment
United States
7 participants16 participants23 participants
Sex: Female, Male
Female
3 Participants7 Participants10 Participants
Sex: Female, Male
Male
4 Participants9 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 160 / 7
serious
Total, serious adverse events
0 / 160 / 7

Outcome results

Primary

Number of Days With Pain Scores >3 Measured on Numeric Rating Scale (Range 0-10; 0 for no Pain; 10 for Worst Pain Imaginable)

days of pain \>3 by nurses notes based on pain scores on numeric rating scale (up to 28 days)

Time frame: 7 days pre to 21 days post transplant = 28 days

Population: ITT no imputations

ArmMeasureValue (MEAN)Dispersion
MassageNumber of Days With Pain Scores >3 Measured on Numeric Rating Scale (Range 0-10; 0 for no Pain; 10 for Worst Pain Imaginable)7.7 days95% Confidence Interval 4.9
ControlNumber of Days With Pain Scores >3 Measured on Numeric Rating Scale (Range 0-10; 0 for no Pain; 10 for Worst Pain Imaginable)8.3 days95% Confidence Interval 5.5
Comparison: comparison between groups by t-testp-value: 0.895% CI: [-5.4, 4.2]t-test, 2 sided
Secondary

Days of Hospital Stay

days of hospital stay after bone marrow transplant (up to 100 days; participant observation was censored after 100 days)

Time frame: days of hospital stay after bone marrow transplant

Population: ITT

ArmMeasureValue (MEAN)
MassageDays of Hospital Stay39.1 number of days
ControlDays of Hospital Stay35.3 number of days
p-value: 0.7895% CI: [-31.9, 24.3]t-test, 2 sided
Secondary

Days to Recovery Neutrophil Count

number of days to recovery neutrophil count \>500 cells per microliter for 2 consecutive days (range, up to 100 days, censored at 100 days)

Time frame: hospital stay

ArmMeasureValue (MEAN)Dispersion
MassageDays to Recovery Neutrophil Count16.8 number of days95% Confidence Interval 14.3
ControlDays to Recovery Neutrophil Count18.7 number of days
p-value: 0.795% CI: [-9.5, 13.2]t-test, 2 sided
Secondary

Number of Vomiting Episodes

number of vomiting episodes as reported by nurses per occurence (no upper limit)

Time frame: day -7 to +21 around transplant date

Population: ITT

ArmMeasureValue (MEAN)
MassageNumber of Vomiting Episodes4.6 number of episodes
ControlNumber of Vomiting Episodes7.0 number of episodes
p-value: 0.2995% CI: [-6.9, 2.1]t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026